ALLMedicine™ Cataracts Center
Research & Reviews 1,760 results
https://doi.org/10.3390/ijerph19095295
International Journal of Environmental Research and Publi... Essuman VA, Tagoe NN et. al.
May 15th, 2022 - The main objective of the study was to determine the prevalence of diabetic retinopathy (DR), other diabetes-related ocular changes (e.g., cataracts, corneal ulceration), and non-diabetic ocular disease in Ghanaian children and adolescents. The se...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065199
Theranostics Ding N, Wang K et. al.
May 14th, 2022 - Background: Impaired mitochondrial function contributes to non-alcoholic steatohepatitis (NASH). Acylglycerol kinase (AGK) is a subunit of the translocase of the mitochondrial inner membrane 22 (TIM22) protein import complex. AGK mutation is the l...
https://clinicaltrials.gov/ct2/show/NCT02771236
May 13th, 2022 - Objective: This project, Clinical and Molecular Studies in Families with Inherited Eye Disease will study inherited eye diseases, both Mendelian and complex age related inherited eye diseases, in families of many nationalities and ethnic backgroun...
https://clinicaltrials.gov/ct2/show/NCT00594672
May 13th, 2022 - The Age-Related Eye Disease Study (AREDS) Follow-Up protocol allows us to continue with the follow-up of participants who were enrolled in the clinical trial of antioxidant vitamins and zinc. The AREDS study was designed in the beginning to determ...
https://doi.org/10.21037/apm-22-222
Annals of Palliative Medicine; Wu L, Chen Z et. al.
May 7th, 2022 - For patients with cataracts and retinopathy, phacoemulsification can improve the progress of the disease to a certain extent. However, the efficacy of phacoemulsification alone is often not ideal, and may even aggravate the prognostic effects, suc...
Guidelines 3 results
https://allmedx.com/USPSTFPDF/viselderscrsumm.pdf
Feb 23rd, 2016 - Screening for Impaired Visual Acuity in Older Adults: Clinical Summary Population Adults 65 years or older who do not present with vision problems Recommendation No recommendation. Grade: I (insufficient evidence) Risk Assessment Older a...
https://doi.org/10.7326/0003-4819-151-1-200907070-00007
Annals of Internal Medicine;
Jul 8th, 2009 - Update of the 1996 U.S. Preventive Services Task Force (USPSTF) recommendation statement on screening for visual impairment. The USPSTF reviewed evidence published since its last review on screening adults 65 years or older in the primary care set...
https://www.nccih.nih.gov/health/tips/things-to-know-about-dietary-supplements-for-eye-conditions
National Center for Complementary and Integrative Health (NCCIH)
Many people turn to dietary supplements to try to prevent or slow the progression of eye conditions such as age-related macular degeneration (AMD), glaucoma, or cataracts. Here are 5 things you should know if you are considering taking dietary sup...
Drugs 44 results see all →
Clinicaltrials.gov 85 results
https://clinicaltrials.gov/ct2/show/NCT02771236
May 13th, 2022 - Objective: This project, Clinical and Molecular Studies in Families with Inherited Eye Disease will study inherited eye diseases, both Mendelian and complex age related inherited eye diseases, in families of many nationalities and ethnic backgroun...
https://clinicaltrials.gov/ct2/show/NCT00594672
May 13th, 2022 - The Age-Related Eye Disease Study (AREDS) Follow-Up protocol allows us to continue with the follow-up of participants who were enrolled in the clinical trial of antioxidant vitamins and zinc. The AREDS study was designed in the beginning to determ...
https://clinicaltrials.gov/ct2/show/NCT04340505
Apr 28th, 2022 - Prospective imaging of the intrAvitreal fluocinoloNe acetonide implant using fluorescein angiography and opTical coHerencE tomogRaphy in uveitis patients. (PANTHER) Background Uveitis, a disease with high visual morbidity Uveitis accounts for up t...
https://clinicaltrials.gov/ct2/show/NCT03908359
Apr 27th, 2022 - Patients with congenital cataract that requires surgical intervention are enrolled. Then the participants are assigned to two groups: Group I: the participants receive a minimal invasive lens surgery, while in Group II, the participants receive a ...
https://clinicaltrials.gov/ct2/show/NCT05336422
Apr 20th, 2022 - The UV index in Mayotte and Reunion is greater than 14, eight months out of twelve. This index decreases linearly over the period from mid-April to mid-August where it can drop to reach an index of 8 in July. The inhabitants are therefore exposed ...
News 319 results
https://www.onclive.com/view/treatment-of-keratopathy-associated-with-belantamab-mafodotin
Mar 20th, 2022 - Sagar Lonial, MD, FACP: Dr Klugo, I want to come back to some of the belantamab [mafodotin]-associated keratopathy. You mentioned the KVA [Keratopathy and Visual Acuity] scale as a way to measure severity. Are there any data on how to treat belama...
https://www.onclive.com/view/belantamab-mafodotin-dosing-strategies-in-patients-with-rrmm
Mar 14th, 2022 - Sagar Lonial, MD, FACP: I’ve had cases where I treated patients and they developed keratopathy that required me to hold a dose, it resolves or completely goes away, then I retreat them, and then it’s back in a cycle or two. Then I hold again and i...
https://www.mdedge.com/dermatology/article/251390/pigmentation-disorders/lower-leg-hyperpigmentation-myh9-related-disorder
Ashley N. Elsensohn, MD, MPH, Logan William Thomas, MD et. al.
Feb 3rd, 2022 - To the Editor: MYH9-related disorder is an autosomal-dominant disorder characterized by macrothrombocytopenia and neutrophil inclusions secondary to defective myosin-9. 1 We describe a case of lower leg hyperpigmentation secondary to hemosiderin de.
https://www.medscape.com/viewarticle/964605
Dec 10th, 2021 - Older patients who undergo cataract surgery may reduce their risk of developing dementia by roughly 30%, new research shows. Dr Cecilia Lee Although previous studies have linked sensory impairment to dementia, whether correcting vision problems in...
https://www.onclive.com/view/fgfr-targeted-therapy-for-metastatic-urothelial-cancer
Dec 6th, 2021 - Arlene O. Siefker-Radtke, MD: With the erdafitinib [Balversa] approval in locally advanced or metastatic bladder cancer, have you used erdafitinib much in your own practice? Scott T. Tagawa, MD, MS, FACP: Yes. I guess the definition of much is al...